Clinical Trials Browser

Enrolling by invitation × S 1 (combination) × Clear all

NCT06901622 2025-03-30

Camrelizumab and Chemotherapy With or Without Anlotinib as First-line Treatment for Advanced Gallbladder Cancer and Extrahepatic Cholangiocarcinoma

Phase 2 Enrolling by invitation

Gastrointestinal

Gallbladder Neoplasms, Cholangiocarcinoma

NCT04260269 2024-12-12

CardioSwitch

Enrolling by invitation

Other solid neoplasm

Solid Tumor

NCT06487715 2024-07-05

Safety and Efficacy of Systemic Chemotherapy Plus PD-1 Inhibitor in Combination With Bevacizumab in Gastric Cancer With Peritoneal Metastasis

Phase 2 Enrolling by invitation

Gastrointestinal

Gastric Cancer Peritoneal Metastases